Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Alkermes plc. (ALKS), most recent 12 months reported: revenue $1.67B, net income $66.12M, free cash flow $480.33M. Latest balance sheet on file: liquid cash $656.58M. From SEC filings. More on Alkermes plc.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: United Therapeutics Corporation · AMNEAL PHARMACEUTICALS, INC. · Royalty Pharma plc · SAREPTA THERAPEUTICS, INC. · Phibro Animal Health Corporation · Indivior Pharmaceuticals, Inc. · MADRIGAL PHARMACEUTICALS, INC. · ACADIA PHARMACEUTICALS INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.